Lactic acidosis historical perspective

Jump to navigation Jump to search

Lactic acidosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Lactic acidosis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Lactic acidosis historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lactic acidosis historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lactic acidosis historical perspective

CDC on Lactic acidosis historical perspective

Lactic acidosis historical perspective in the news

Blogs on Lactic acidosis historical perspective

Directions to Hospitals Treating Lactic acidosis

Risk calculators and risk factors for Lactic acidosis historical perspective

Overview

Lactic acid was first found and described in sour milk by Karl Wilhelm Scheele (1742–1786) in 1780. The German physician–chemist Johann Joseph Scherer (1841–1869) was the first to demonstrate the presence of lactic acid in human blood in 1843 and 1851. His 1843 case reports are the first description of lactic acid in human blood post-mortem and as a pathological finding in septic and haemorrhagic shock. Carl Folwarczny, an Austrian physician, was the first to demonstrate lactic acid in blood in a living patient in 1858.

Discovery

  • In 1843, Scherer highlighted in his book that lactic acid was present in patients of puerperal fever and not in healthy people. He was of the mind that lactic acid was formed in blood during breakdown of tissue in puerperal fever and other severe diseases. Thus, lactic acid was recorded in human blood for the first time and was associated for the first time with symptoms of septic and haemorrhagic shock.
  • in 1858, Carl Folwarczny drew blood from a leukaemia patient during life and analysed it according to Scherer's method, which tested positive for lactic acid. In 1863, Folwarczny described that lactic acid can be found in the blood of patients with leukaemia, septicaemia (pyaemia) and related conditions such as puerperal fever.
  • Georg Salomon proved in 1878 that lactic acid was also present in the blood of patients who were suffering and died from other diseases. He studied blood obtained during autopsy from cadavers, but also blood from patients obtained by bloodletting or cupping, and in some cases he compared the blood before and after death. He was able to demonstrate lactic acid in the blood of patients suffering from leukaemia, (pernicious) anaemia, congestive heart failure, chronic obstructive pulmonary disease, pleuritis, pericarditis, pneumonia and several solid malignant tumours.
  • Walter Morley Fletcher (1873–1933) and Frederick Gowland Hopkins (1861–1947), in their 1907 paper demonstrated that anaerobic formation of lactic acid occurs simultaneously with muscle contraction, and is removed aerobically (depending on the availability of oxygen).
  • In 1925, Clausen identified that buildup of lactic acid in blood underlies acid-base disorders.
  • In 1961, Huckabee established that lactic acidosis frequently accompanies severe illnesses and it can be attributed to widespread tissue hypoxia.
  • In 1976, Cohen and Woods classified the lactic acidosis according to the presence or absence of adequate tissue oxygenation.

Landmark Events in the Development of Treatment Strategies

References


Template:WikiDoc Sources